Global Targeted lncRNA Single Cell Sequencing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI07248912

Publication Date:

July 25, 2024

Pages:

139

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

LncRNA is non-coding RNA with a length of more than 200 nucleotides. Compared with mRNA, lncRNA is generally low in expression and has stronger tissue specificity. As a hot spot of RNA research, lncRNA regulates the expression of coding genes at various levels, including epigenetic inheritance, transcription and post-transcription. Different from traditional chip inspection, lncRNA analysis combined with high-throughput sequencing technology and bioinformatics analysis can comprehensively excavate the information of lncRNA in samples. LncRNA sequencing technology has been widely used in genetic improvement of species, and disease studies on occurrence, development, diagnosis, and treatment.
The global Targeted lncRNA Single Cell Sequencing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the 鈥淭argeted lncRNA Single Cell Sequencing Industry Forecast鈥� looks at past sales and reviews total world Targeted lncRNA Single Cell Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted lncRNA Single Cell Sequencing sales for 2023 through 2029. With Targeted lncRNA Single Cell Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted lncRNA Single Cell Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Targeted lncRNA Single Cell Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted lncRNA Single Cell Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Targeted lncRNA Single Cell Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted lncRNA Single Cell Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted lncRNA Single Cell Sequencing.
United States market for Targeted lncRNA Single Cell Sequencing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Targeted lncRNA Single Cell Sequencing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Targeted lncRNA Single Cell Sequencing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Targeted lncRNA Single Cell Sequencing players cover Aksomics, Anshengda, BGI, Annuoyouda Gene Technology, LC Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted lncRNA Single Cell Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Equipment Supplies
Service
Segmentation by Application:
Developmental Biology
Oncology
Neuroscience
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Equipment Supplies
Service
Segmentation by Application:
Developmental Biology
Oncology
Neuroscience
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Aksomics
Anshengda
BGI
Annuoyouda Gene Technology
LC Sciences
Creative Biolabs
Eurofins Scientific
CD Genomics
Novogene
Beijing Compson Biotechnology Co., Ltd.
Biomark Biotechnology
BD
10x Genomics
Majorbio
QIAGEN
Roche

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted lncRNA Single Cell Sequencing Market Size 2019-2030
2.1.2 Targeted lncRNA Single Cell Sequencing Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Targeted lncRNA Single Cell Sequencing by Country/Region, 2019, 2023 & 2030
2.2 Targeted lncRNA Single Cell Sequencing Segment by Type
2.2.1 Equipment Supplies
2.2.2 Service
2.3 Targeted lncRNA Single Cell Sequencing Market Size by Type
2.3.1 Targeted lncRNA Single Cell Sequencing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted lncRNA Single Cell Sequencing Market Size Market Share by Type (2019-2024)
2.4 Targeted lncRNA Single Cell Sequencing Segment by Application
2.4.1 Developmental Biology
2.4.2 Oncology
2.4.3 Neuroscience
2.4.4 Other
2.5 Targeted lncRNA Single Cell Sequencing Market Size by Application
2.5.1 Targeted lncRNA Single Cell Sequencing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted lncRNA Single Cell Sequencing Market Size Market Share by Application (2019-2024)
3 Targeted lncRNA Single Cell Sequencing Market Size by Player
3.1 Targeted lncRNA Single Cell Sequencing Market Size Market Share by Player
3.1.1 Global Targeted lncRNA Single Cell Sequencing Revenue by Player (2019-2024)
3.1.2 Global Targeted lncRNA Single Cell Sequencing Revenue Market Share by Player (2019-2024)
3.2 Global Targeted lncRNA Single Cell Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Targeted lncRNA Single Cell Sequencing by Region
4.1 Targeted lncRNA Single Cell Sequencing Market Size by Region (2019-2024)
4.2 Global Targeted lncRNA Single Cell Sequencing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Targeted lncRNA Single Cell Sequencing Market Size Growth (2019-2024)
4.4 APAC Targeted lncRNA Single Cell Sequencing Market Size Growth (2019-2024)
4.5 Europe Targeted lncRNA Single Cell Sequencing Market Size Growth (2019-2024)
4.6 Middle East & Africa Targeted lncRNA Single Cell Sequencing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Targeted lncRNA Single Cell Sequencing Market Size by Country (2019-2024)
5.2 Americas Targeted lncRNA Single Cell Sequencing Market Size by Type (2019-2024)
5.3 Americas Targeted lncRNA Single Cell Sequencing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted lncRNA Single Cell Sequencing Market Size by Region (2019-2024)
6.2 APAC Targeted lncRNA Single Cell Sequencing Market Size by Type (2019-2024)
6.3 APAC Targeted lncRNA Single Cell Sequencing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Targeted lncRNA Single Cell Sequencing Market Size by Country (2019-2024)
7.2 Europe Targeted lncRNA Single Cell Sequencing Market Size by Type (2019-2024)
7.3 Europe Targeted lncRNA Single Cell Sequencing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Targeted lncRNA Single Cell Sequencing by Region (2019-2024)
8.2 Middle East & Africa Targeted lncRNA Single Cell Sequencing Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted lncRNA Single Cell Sequencing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Targeted lncRNA Single Cell Sequencing Market Forecast
10.1 Global Targeted lncRNA Single Cell Sequencing Forecast by Region (2025-2030)
10.1.1 Global Targeted lncRNA Single Cell Sequencing Forecast by Region (2025-2030)
10.1.2 Americas Targeted lncRNA Single Cell Sequencing Forecast
10.1.3 APAC Targeted lncRNA Single Cell Sequencing Forecast
10.1.4 Europe Targeted lncRNA Single Cell Sequencing Forecast
10.1.5 Middle East & Africa Targeted lncRNA Single Cell Sequencing Forecast
10.2 Americas Targeted lncRNA Single Cell Sequencing Forecast by Country (2025-2030)
10.2.1 United States Market Targeted lncRNA Single Cell Sequencing Forecast
10.2.2 Canada Market Targeted lncRNA Single Cell Sequencing Forecast
10.2.3 Mexico Market Targeted lncRNA Single Cell Sequencing Forecast
10.2.4 Brazil Market Targeted lncRNA Single Cell Sequencing Forecast
10.3 APAC Targeted lncRNA Single Cell Sequencing Forecast by Region (2025-2030)
10.3.1 China Targeted lncRNA Single Cell Sequencing Market Forecast
10.3.2 Japan Market Targeted lncRNA Single Cell Sequencing Forecast
10.3.3 Korea Market Targeted lncRNA Single Cell Sequencing Forecast
10.3.4 Southeast Asia Market Targeted lncRNA Single Cell Sequencing Forecast
10.3.5 India Market Targeted lncRNA Single Cell Sequencing Forecast
10.3.6 Australia Market Targeted lncRNA Single Cell Sequencing Forecast
10.4 Europe Targeted lncRNA Single Cell Sequencing Forecast by Country (2025-2030)
10.4.1 Germany Market Targeted lncRNA Single Cell Sequencing Forecast
10.4.2 France Market Targeted lncRNA Single Cell Sequencing Forecast
10.4.3 UK Market Targeted lncRNA Single Cell Sequencing Forecast
10.4.4 Italy Market Targeted lncRNA Single Cell Sequencing Forecast
10.4.5 Russia Market Targeted lncRNA Single Cell Sequencing Forecast
10.5 Middle East & Africa Targeted lncRNA Single Cell Sequencing Forecast by Region (2025-2030)
10.5.1 Egypt Market Targeted lncRNA Single Cell Sequencing Forecast
10.5.2 South Africa Market Targeted lncRNA Single Cell Sequencing Forecast
10.5.3 Israel Market Targeted lncRNA Single Cell Sequencing Forecast
10.5.4 Turkey Market Targeted lncRNA Single Cell Sequencing Forecast
10.6 Global Targeted lncRNA Single Cell Sequencing Forecast by Type (2025-2030)
10.7 Global Targeted lncRNA Single Cell Sequencing Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Targeted lncRNA Single Cell Sequencing Forecast
11 Key Players Analysis
11.1 Aksomics
11.1.1 Aksomics Company Information
11.1.2 Aksomics Targeted lncRNA Single Cell Sequencing Product Offered
11.1.3 Aksomics Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Aksomics Main Business Overview
11.1.5 Aksomics Latest Developments
11.2 Anshengda
11.2.1 Anshengda Company Information
11.2.2 Anshengda Targeted lncRNA Single Cell Sequencing Product Offered
11.2.3 Anshengda Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Anshengda Main Business Overview
11.2.5 Anshengda Latest Developments
11.3 BGI
11.3.1 BGI Company Information
11.3.2 BGI Targeted lncRNA Single Cell Sequencing Product Offered
11.3.3 BGI Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 BGI Main Business Overview
11.3.5 BGI Latest Developments
11.4 Annuoyouda Gene Technology
11.4.1 Annuoyouda Gene Technology Company Information
11.4.2 Annuoyouda Gene Technology Targeted lncRNA Single Cell Sequencing Product Offered
11.4.3 Annuoyouda Gene Technology Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Annuoyouda Gene Technology Main Business Overview
11.4.5 Annuoyouda Gene Technology Latest Developments
11.5 LC Sciences
11.5.1 LC Sciences Company Information
11.5.2 LC Sciences Targeted lncRNA Single Cell Sequencing Product Offered
11.5.3 LC Sciences Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 LC Sciences Main Business Overview
11.5.5 LC Sciences Latest Developments
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Information
11.6.2 Creative Biolabs Targeted lncRNA Single Cell Sequencing Product Offered
11.6.3 Creative Biolabs Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Creative Biolabs Main Business Overview
11.6.5 Creative Biolabs Latest Developments
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Company Information
11.7.2 Eurofins Scientific Targeted lncRNA Single Cell Sequencing Product Offered
11.7.3 Eurofins Scientific Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Eurofins Scientific Main Business Overview
11.7.5 Eurofins Scientific Latest Developments
11.8 CD Genomics
11.8.1 CD Genomics Company Information
11.8.2 CD Genomics Targeted lncRNA Single Cell Sequencing Product Offered
11.8.3 CD Genomics Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 CD Genomics Main Business Overview
11.8.5 CD Genomics Latest Developments
11.9 Novogene
11.9.1 Novogene Company Information
11.9.2 Novogene Targeted lncRNA Single Cell Sequencing Product Offered
11.9.3 Novogene Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novogene Main Business Overview
11.9.5 Novogene Latest Developments
11.10 Beijing Compson Biotechnology Co., Ltd.
11.10.1 Beijing Compson Biotechnology Co., Ltd. Company Information
11.10.2 Beijing Compson Biotechnology Co., Ltd. Targeted lncRNA Single Cell Sequencing Product Offered
11.10.3 Beijing Compson Biotechnology Co., Ltd. Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Beijing Compson Biotechnology Co., Ltd. Main Business Overview
11.10.5 Beijing Compson Biotechnology Co., Ltd. Latest Developments
11.11 Biomark Biotechnology
11.11.1 Biomark Biotechnology Company Information
11.11.2 Biomark Biotechnology Targeted lncRNA Single Cell Sequencing Product Offered
11.11.3 Biomark Biotechnology Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Biomark Biotechnology Main Business Overview
11.11.5 Biomark Biotechnology Latest Developments
11.12 BD
11.12.1 BD Company Information
11.12.2 BD Targeted lncRNA Single Cell Sequencing Product Offered
11.12.3 BD Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 BD Main Business Overview
11.12.5 BD Latest Developments
11.13 10x Genomics
11.13.1 10x Genomics Company Information
11.13.2 10x Genomics Targeted lncRNA Single Cell Sequencing Product Offered
11.13.3 10x Genomics Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 10x Genomics Main Business Overview
11.13.5 10x Genomics Latest Developments
11.14 Majorbio
11.14.1 Majorbio Company Information
11.14.2 Majorbio Targeted lncRNA Single Cell Sequencing Product Offered
11.14.3 Majorbio Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Majorbio Main Business Overview
11.14.5 Majorbio Latest Developments
11.15 QIAGEN
11.15.1 QIAGEN Company Information
11.15.2 QIAGEN Targeted lncRNA Single Cell Sequencing Product Offered
11.15.3 QIAGEN Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 QIAGEN Main Business Overview
11.15.5 QIAGEN Latest Developments
11.16 Roche
11.16.1 Roche Company Information
11.16.2 Roche Targeted lncRNA Single Cell Sequencing Product Offered
11.16.3 Roche Targeted lncRNA Single Cell Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Roche Main Business Overview
11.16.5 Roche Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂